Back
FlexShares Real Assets Allocation ETF Vs. Dyne Therapeutics Industry Stock Comparison
Buy
54
ASET
FlexShares Real Assets Allocation ETF
Last Price:
30.28
Seasonality Move:
0.82%
Buy
64
DYN
Dyne Therapeutics
Last Price:
35.41
Seasonality Move:
29.58%
Buy
54
FlexShares Real Assets Allocation ETF (ASET)
is a Buy
Is FlexShares Real Assets Allocation ETF a Buy, Sell or Hold?
- The current FlexShares Real Assets Allocation ETF [ASET] share price is $30.38. The Score for ASET is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ASET is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.92. The Score for DYN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ASET Stock Price Chart
What is FlexShares Real Assets Allocation ETF's stock price today?
-
The FlexShares Real Assets Allocation ETF share price today is $30.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASET is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 45.3 | Sell |
Chaikin Money Flow: | 973 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.29 - 31.07) | Sell |
Bollinger Bands (100): | (29.94 - 31.04) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | 599904 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.98 - 33.66) | Buy |
Bollinger Bands (100): | (23.98 - 30.96) | Buy |
ASET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.31 | Buy |
20-day SMA: | 30.57 | Sell |
50-day SMA: | 30.69 | Sell |
200-day SMA: | 29.85 | Buy |
8-day EMA: | 30.41 | Sell |
20-day EMA: | 30.54 | Sell |
50-day EMA: | 30.63 | Sell |
200-day EMA: | 30.24 | Buy |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.61 | Buy |
20-day SMA: | 32.56 | Buy |
50-day SMA: | 29.25 | Buy |
200-day SMA: | 19.48 | Buy |
8-day EMA: | 33.72 | Buy |
20-day EMA: | 32.57 | Buy |
50-day EMA: | 30.2 | Buy |
200-day EMA: | 22.36 | Buy |
FlexShares Real Assets Allocation ETF Earnings Growth & ASET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
FlexShares Real Assets Allocation ETF Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |